Sort
50,496 grants matching “lung cancer”
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$661,394Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Patho-Genetic Analysis of Invasive Mucinous Adenocarcinoma of the Lung
$661,391Yutaka Maeda · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
Preoperative Respiratory Muscle Training to Prevent Postoperative Pulmonary Complications in Patients Undergoing Resection for Lung Cancer
$661,363Andrew Donald Ray · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Immunotherapy for Malignant Mesothelioma
$661,211Raffit Hassan · Basic Sciences · Z01 · FY2007 · CA
Novel proteasome inhibitors targeting both beta5 and beta2 subunits for treatment of triple negative breast cancer
$661,147Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer Disparities in Appalachia
$661,139Brittney L Keller-Hamilton · Ohio State University · R01 · FY2024 · CA
Biomarkers to Assess Selenium Chemoprevention for NSCLC
$661,128Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2008 · CA
Optimizing Dual-Targeted and Dual-Armored CAR T Cells for Small Cell Lung Cancer
$661,095Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · U01 · FY2021 · CA
Case-Control Study of Pancreas Cancer Etiologic Factors
$661,093Yale University · R01 · FY2003 · CA
Develop a novel therapy with immuno- and onco-targeting dual efficacies to treat the triple negative breast cancer
$661,072Deyu Fang · Northwestern University At Chicago · R01 · FY2025 · CA
Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer
$661,067Kwok Kin Wong · New York University School Of Medicine · U01 · FY2018 · CA
Probe-based two photon microscopy for functional, label-free early cancer diagnosis
$661,053Irene Georgakoudi · Tufts University Medford · R01 · FY2023 · EB
Tumor Microenvironment in Cancer Progression
$661,011Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Engineering Dual-Targeted Nanoplatforms to Effectively Treat NSCLC.
$661,001Raghuraman Kannan · University Of Missouri-Columbia · R01 · FY2023 · EB
Clinical translation of a PD-L1 PET tracer to optimize immune checkpoint therapy in patients with non-small cell lung cancers
$660,982Sridhar Nimmagadda · Johns Hopkins University · R01 · FY2023 · CA
Targeting the Mitochondria to Overcome Resistance to Immune Checkpoint Inhibition in Malignant Pleural Mesothelioma
$660,954Robert Taylor Ripley · Baylor College Of Medicine · R37 · FY2024 · CA
Advancing Geriatrics Infrastructure & Network Growth
$660,932Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R24 · FY2015 · AG
Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer
$660,920Eric Collisson · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers
$660,742Lauren Elizabeth Colbert · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
Role of NSD3 in regulation of cancer pathogenesis
$660,709Pawel K. Mazur · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Studies of Atomic Bomb Survivors
$660,698Kiyohiko Mabuchi · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
A Decision Aid with HRQL Assessment to Reduce Costs in the Treatment of NSCLC
$660,655Patricia Jean Hollen · University Of Virginia · R01 · FY2012 · CA
Understanding and addressing rejection of personalized cancer risk information
$660,513Laura D. Scherer · University Of Colorado Denver · R01 · FY2023 · CA
CardioWatch: An Omics-Based Prediction Assay for Cardiac Late Effects ofAcute Radiation
$660,437Tomas Kanholm · Nelson Scientific Labs Llc · R44 · FY2025 · AI
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
$660,333Kathryn L Taylor · Georgetown University · R01 · FY2023 · CA